BioCell Technology, a research and product development company, has launched BioCell Collagen ERP (Extra Refined Palatable), a new ingredient tailored for sensory delivery formats such as gummies, lozenges, and chewables.
BioCell Collagen ERP delivers the same naturally occurring matrix of hydrolysed collagen type II peptides, chondroitin sulphate, and hyaluronic acid found in BioCell Collagen, optimised for enhanced palatability in consumer-friendly applications.
BioCell Technology CEO Mo Ishaq said: “We are introducing BioCell Collagen ERP to support our customers seeking to reach consumers who prefer taking supplements in a non-pill format.
“We’ve invested in an advanced refining process that delivers BioCell Collagen ERP as a fine white to off-white powder with a natural and neutral taste that can support a range of wide product flavours without interfering in the intended product taste.”
Ishaq added: “This process produces a smooth and easy texture for BioCell Collagen ERP to contribute to the pleasurable palate experience of sensory delivery formats like gummies.”
BioCell Collagen is one of the few science-backed dietary supplement ingredients designed to address the physiological degradation of connective tissue and the associated age-related loss of structurally essential molecules.
As a clinically tested branded dietary ingredient, research has shown that BioCell Collagen supports active joints, youthful-looking skin, and healthy connective tissues.
Over a decade of research, including multiple human clinical trials, demonstrates its ability to combat visible signs of ageing – such as wrinkles, fine lines, and crow’s feet – while providing internal benefits for joint and connective tissue health.
These effects are attributed to BioCell Collagen’s unique composition of naturally occurring hydrolysed collagen type II peptides, chondroitin sulphate, and hyaluronic acid.
Unlike many collagen supplements, BioCell Collagen delivers its ingredients in a highly absorbable matrix form rather than as a blend of individual components.
The proprietary matrix has been extensively studied in human clinical trials, which confirm its safety, efficacy, and bioavailability, setting it apart as a superior option in the collagen supplement market.
The launch of BioCell Collagen ERP comes at a time when new market research highlights collagen as a growing entry point and key purchase motivator for consumers in the supplement market.
Collagen Stewardship Alliance is part of the Industry Transparency Center, which issued their 2024 Insights on Collagen Users in June.
Collagen Stewardship Alliance CEO Len Monheit said: “Our new research shows that skin health continues to be a priority for consumers to purchase and take dietary supplements – that places collagen as a leading ingredient on a top health concern that motivates consumers to engage with the supplement market.”
“Our 2024 survey also shows that joint health and concerns over joint discomfort has moved up as a top health concern motivator for supplement purchase.”
Ishaq said: “New Collagen Stewardship Alliance data shows that consumers are highly motivated to engage with supplements for skin health and joint mobility concerns. This data may indicate an evolution in consumer behaviour, especially for joint health.
“A new generation of adults who are taking a proactive approach to their wellness may be looking more to the proven benefits of collagen for joint health. It’s worth exploring new ways to serve their growing interest.”
